May 2, 2007 by Mike HavrillaConsider CortexNew findings may give Cortex's ADHD drug the lift it needs.
May 1, 2007 by Mike HavrillaHeads Up, Biotech InvestorsBig news is in the offing for these companies.
Apr 30, 2007 by Mike HavrillaVIVUS Revives Investor InterestNew drugs with huge markets could keep shares of VIVUS on their upward trajectory.
Apr 30, 2007 by Mike HavrillaThermoGenesis Is Ready to Heat UpAs it nears profitability, ThermoGenesis is positioned for gains.
Apr 27, 2007 by Mike HavrillaDetecting an Opportunity in EXACT SciencesThanks to a strong balance sheet and low burn rate, shares of EXACT are poised to go up in the next few months.
Apr 27, 2007 by Mike HavrillaMonitoring Shares of VISICUStrong numbers and strong patent cases bode well for VISICU.
Apr 26, 2007 by Mike HavrillaDendreon Is Worth a ShotProvenge might be approved, which means investors might be rewarded.
Apr 26, 2007 by Mike HavrillaXenoport Soothes Investors' Restless HeartsShares surge on positive trial results of an experimental drug for restless legs.
